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prefer, the less intuitive term negative
predictive value). Although the FN or
false-positive rate is sometimes criti-
cized for being influenced by the prev-
alence, this effect primarily occurs at
extremely high or low prevalence (not
in the range of prevalence among the
patients in this study). As I calculate
the results for all patients (regardless
of size), the FN rate is 5%, 9%, and
7% for the C/T ratio, tumor disappear-
ance ratio, and visual estimation meth-
ods, respectively. I wish the authors
would report the FN rates for the three
methods for tumors less than 2 cm.
They have not provided enough data to
allow this calculation to be made.
In addition, although vascular
invasion and lymphatic invasion have
been widely viewed as surrogate
markers for tumor dissemination to
nodes or distant sites in Japan, this has
been less well adopted in other parts of
the world. Furthermore, I would argue
that the issue in question is local
spread (i.e. nodal metastasis) when
considering lobar versus sublobar re-
section (if distant metastasis has oc-
curred, it will not be influenced by the
extent of local resection). Therefore, I
think that focusing on a surrogate such
as vascular or lymphatic invasion may
not be as relevant as the actual occur-
rence of nodal metastasis. I wish the
authors would specifically report the
incidence of nodal involvement for tu-
mors with a C/T ratio, tumor disap-
pearance ratio, and visual estimation
ratio of less than 0.5 (for lesions of all
sizes as well as only those 2 cm).
Once again, I wish to commend
the authors for their substantial contri-
butions to the clinical science of lung
cancer.
Frank C. Detterbeck, MD
Division of Thoracic Surgery
Department of Surgery
Yale University
New Haven, Connecticut
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JCOG0201 Defined
“Radiological Early
Peripheral Lung
Adenocarcinoma”
To the Editor:
In our article entitled, “A Pro-
spective Radiological Study of Thin-
Section Computed Tomography to
Predict Pathological Noninvasiveness
in Peripheral Clinical IA Lung Cancer
(JCOG0201),” we made a comparison
between radiological findings of
ground glass attenuation on thin-sec-
tion computed tomography and patho-
logical invasiveness such as lymph
node metastasis. Sensitivity and spec-
ificity were evaluated in this article,
and the definition of radiological early
peripheral lung cancer was clarified
for the first time. It is difficult for
readers to interpret those data because
of its unique method and mode for
defining radiological early lung can-
cer.1 However, Dr. Detterbeck’s ques-
tion definitely hit the nail of the head.
We agree with him on that most sur-
geons need information on lymph
node metastasis instead of vascular or
lymphatic invasion. We actually pre-
pared the data for submitting, but it
was not possible for the limitation of
the number of the tables. As to the
false-negative cases for invasiveness
in lung cancer 2 cm or less in size, the
following table is added (Table 1).
This table contains data on lung cancer
2.0 cm or less in size and cutoff of 0.5,
that is, the size of consolidation less
than half of the maximum tumor di-
mension. As to nodal invasion for ra-
diological early lung cancer, we are
preparing manuscript on this matter.
We are sure to submit the information
in the near future.
In addition, we have already con-
ducted phase II trial named JCOG0804
for limited surgical resection for the “ra-
diological early lung cancer” defined by
the JCOG0201. Accrual of patients has
just been completed, and we will con-
clude whether our criteria for early lung
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TABLE 1. Radiologic-Pathologic Correlation in Lung Cancer 2.0 cm or Less in Size
(Cutoff: 0.5)
Radiology (Cutoff: 0.5)a
Pathological Diagnosisb
Noninvasive Invasive
Consolidation/tumor ratio on lung window
Noninvasivea 65 2
Invasive 145 77
Sensitivity 31.0% (95% CI: 24.8–37.7)
Specificity 97.5% (95% CI: 91.2–99.7)
TDR
Noninvasivea 101 10
Invasive 109 69
Sensitivity 48.1% (95% CI: 41.2–55.1)
Specificity 87.3% (95% CI: 78.0–93.8)
Visual estimation of consolidation
Noninvasivea 84 7
Invasive 126 72
Sensitivity 40.0% (95% CI: 33.3–47.0)
Specificity 91.1% (95% CI: 82.6–96.4)
TDR, tumor disappearance ratio; CI, confidence interval.
a Cutoff for the diagnosis of radiologic noninvasive cancer is 0.5.
b Pathological noninvasive is defined as adenocarcinoma with no nodal involvement, lymphatic invasion, nor
vascular invasion.
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cancers are enough or not in the next 10
years.
We really hope that our prospec-
tive data would lead the world in bet-
ter understanding the management for
peripherally located early lung cancer.
Kenji Suzuki, MD,
on behalf of JCOG Lung Cancer
Surgical Group
Department of General Thoracic Surgery
Juntendo University Hospital
Tokyo, Japan
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